The estimated Net Worth of Jeffrey Bacha is at least $85.4 millier dollars as of 6 October 2017. Jeffrey Bacha owns over 10,000 units of DelMar Pharmaceuticals stock worth over $85,354 and over the last 11 years Jeffrey sold DMPI stock worth over $0.
Jeffrey has made over 18 trades of the DelMar Pharmaceuticals stock since 2014, according to the Form 4 filled with the SEC. Most recently Jeffrey bought 10,000 units of DMPI stock worth $8,700 on 6 October 2017.
The largest trade Jeffrey's ever made was buying 50,000 units of DelMar Pharmaceuticals stock on 16 July 2015 worth over $30,000. On average, Jeffrey trades about 4,806 units every 44 days since 2013. As of 6 October 2017 Jeffrey still owns at least 63,697 units of DelMar Pharmaceuticals stock.
You can see the complete history of Jeffrey Bacha stock trades at the bottom of the page.
Jeffrey's mailing address filed with the SEC is SUITE 720-999 WEST BROADWAY, , VANCOUVER, A1, V5Z 1K5.
Over the last 11 years, insiders at DelMar Pharmaceuticals have traded over $104,000 worth of DelMar Pharmaceuticals stock and bought 663,835 units worth $651,854 . The most active insiders traders include John K Bell, Robert Hoffman et Jeffrey Bacha. On average, DelMar Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $20,766. The most recent stock trade was executed by John K Bell on 13 September 2019, trading 35,000 units of DMPI stock currently worth $23,800.
DelMar Pharmaceuticals, Inc. is a clinical and biopharmaceutical company, which focuses on the development and commercialization of new cancer therapies. It pipeline includes the VAL-083. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.
DelMar Pharmaceuticals executives and other stock owners filed with the SEC include: